There were 1,689 press releases posted in the last 24 hours and 400,281 in the last 365 days.

Diabetes Diagnostics 2015-2022: Global Strategic Business Report 2016 - Medtronic Dominates the Global CGM Devices Market

Dublin, Dec. 16, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Diabetes Diagnostics - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Thousand by the following Product Segments:

  • Continuous Glucose Monitoring (CGM) Systems
  • HbA1c Testing Devices
  • Blood Glucose Monitoring Devices

The report profiles 58 companies including many key and niche players such as

  • Abbott Diabetes Care, Inc. (US)
  • Acon Laboratories, Inc. (US)
  • AgaMatrix, Inc. (US)
  • Alere Inc. (US)
  • Animas Corporation (US)
  • Apex Biotechnology Corporation (Taiwan)
  • ARKRAY, Inc. (Japan)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • A.Menarini Diagnostics Ltd. (UK)
  • B. Braun Melsungen AG (Germany)
  • Becton, Dickinson and Company (US)
  • Bayer Healthcare Diabetes Care (US)
  • Beckman Coulter, Inc. (US)
  • Bio-Rad Laboratories (US)
  • BIONIME Corporation (Taiwan)
  • Diazyme Laboratories Inc. (US)
  • Dexcom, Inc. (US)
  • EKF Diagnostics Holdings Plc (UK)
  • HemoCue® AB (Sweden)
  • Infopia Co., Ltd. (South Korea)
  • LifeScan, Inc. (US)
  • Medtronic MiniMed, Inc. (US)
  • Nova Biomedical Corporation (US)
  • PTS Diagnostics (US)
  • Roche Diagnostics (Switzerland)
  • Sanofi S.A. (France)
  • Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
  • Siemens Healthineers (Germany)
  • Taidoc Technology Corporation (Taiwan)
  • Tandem Diabetes Care, Inc. (US)
  • Terumo Corporation (Japan)
  • Tosoh Bioscience, Inc. (US)
  • Trinity Biotech plc (Ireland)
  • Trividia Health, Inc. (US)
  • Ypsomed AG (Switzerland)

Key Topics Covered:

1. Industry Overview

2. Competition

3. Market Trends, Issues & Drivers

4. Diabetes Diagnostics Innovations & Advancements

5. Product Overview

6. Product Launches

7. Recent Industry Activity

8. Focus On Select Global Players

9. Global Market Perspective

Total Companies Profiled: 58 (including Divisions/Subsidiaries 75)

  • The United States (35)
  • Canada (1)
  • Japan (4)
  • Europe (23)
  • - France (2)
  • - Germany (4)
  • - The United Kingdom (8)
  • - Italy (1)
  • - Rest of Europe (8)
  • Asia-Pacific (Excluding Japan) (10)
  • Middle-East (2)

For more information about this report visit http://www.researchandmarkets.com/research/w859zk/diabetes




CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Diagnostics, Endocrinology 

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.